Novo Nordisk
NVO
#72
Rank
S$289.48 B
Marketcap
S$65.15
Share price
0.36%
Change (1 day)
-55.87%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): S$27.43 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are S$47.21 Billion. In 2024 the company made an earning of S$24.42 Billion, an increase over its 2023 earnings that were of S$19.88 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$27.43 B12.31%
2024 S$24.42 B22.84%
2023 S$19.88 B57.81%
2022 S$12.60 B5.24%
2021 S$11.97 B12.38%
2020 S$10.65 B13.11%
2019 S$9.42 B-3.45%
2018 S$9.75 B1.88%
2017 S$9.57 B4.3%
2016 S$9.18 B10.32%
2015 S$8.32 B7.47%
2014 S$7.74 B3.4%
2013 S$7.48 B19.09%
2012 S$6.28 B15.58%
2011 S$5.44 B16.58%
2010 S$4.66 B25.66%
2009 S$3.71 B10.68%
2008 S$3.35 B55.82%
2007 S$2.15 B7.02%
2006 S$2.01 B19.05%
2005 S$1.69 B10.55%
2004 S$1.52 B
2002 S$1.04 B-14.39%
2001 S$1.22 B-52.82%
2000 S$2.59 B250%
1999 S$0.74 B31.21%
1998 S$0.56 B34.31%
1997 S$0.42 B11.46%
1996 S$0.37 B9.03%
1995 S$0.34 B-3.15%
1994 S$0.35 B-0.67%
1993 S$0.36 B45.38%
1992 S$0.24 B-13.81%
1991 S$0.28 B37.12%
1990 S$0.20 B-0.79%
1989 S$0.21 B26.2%
1988 S$0.16 B24.97%
1987 S$0.13 B-0.9%
1986 S$0.13 B-7.78%
1985 S$0.14 B24.87%
1984 S$0.11 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$15.29 B-43.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$29.04 B 7.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.36 B-61.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.74 B-56.34%๐Ÿ‡ซ๐Ÿ‡ท France